DSG3 and squamous cell lung carcinoma: Previous studies have demonstrated that DSG3 is an accurate biomarker for staging sentinel lymph nodes in head and neck cancer [52, 53], and for distinguishing lung squamous cell carcinoma from other subtypes of lung cancer [54].